ArticleInternational journal of women's health2026
The Effect of Prednisone and Levothyroxine Sodium on Miscarriage Risk and Thyroid Function in Patients with High TPOAb Concentrations: A Retrospective Cohort Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The potential benefit of immunomodulatory therapy in women with high TPOAb concentrations and TSH levels exceeding 2.5 mIU/L remains unclear. This study aimed to evaluate the effects of prednisone combined with levothyroxine sodium (LT4) on miscarriage risk, thyroid function, LT4 dosage and adverse events in this population. Methods: A retrospective cohort study was conducted, in which patients were divided into Group A (treated with levothyroxine sodium tablets alone) and Group B (treated with prednisone combined with levothyroxine sodium tablets). Statistical analyses included chi-square tests, independent sample t-tests, paired sample t-tests and repeated measures ANOVA. Results: Compared with levothyroxine sodium alone, combined treatment significantly reduced miscarriage risk in Group B (P=0.019). TPOAb concentrations in Group B decreased significantly during treatment (P<0.001), while TSH levels showed less fluctuation and remained relatively stable during pregnancy. In addition, Group B required a lower total dose of levothyroxine sodium (P<0.001) and had a lower incidence of adverse reactions. Conclusion: Prednisone combined with levothyroxine sodium was associated with a lower miscarriage rate, more stable thyroid function during pregnancy, and reduced LT4 requirements in patients with high TPOAb concentrations and TSH levels >2.5 mIU/L. These findings suggest that this combined regimen may be a useful option for improving early pregnancy management in this specific patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.